Robert Zakar gives back to community
Retinal Disorders Treatment Market Research Reports: Industry Size, Regional Analysis, And Growth Prospects, 2023 To 2031
The MarketWatch News Department was not involved in the creation of this content.
Apr 25, 2023 (Alliance News via COMTEX) -- Report Ocean's recent report provides an accurate and comprehensive research analysis of the Retinal Disorders Treatmentmarket with a primary focus on the present and past market conditions. The global Retinal Disorders Treatmentmarket is expected to reach US$ Million by 2031, with a CAGR of $$% from 2023 to 2031, based on Report Ocean newly published report.
This research provides a thorough analysis of the worldwide market, and by concentrating on suitable niche markets, this analysis helps the company's growth. The global market study offers the highest return on investment and is built on in-depth research of the world's biggest trends. These fields earn the most money in the world and expand quickly. Additionally, it provides in-depth information about the challenges faced by the sector.
Download Sample of This Strategic Report:https://reportocean.Us/sample-request/report_id/HNY22026
According to this analysis, the geographical regions are categorized according to their production, consumption, revenue (in US dollars), and market share. The report covers the projected growth in this region between 2022 and 2031.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market vendors, types, applications/end users and geography (North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Vendors:
ALLERGANAbbVieAlimera SciencesJanssen BiotechSwedish Orphan BiovitrumRocheBristol-Myers SquibbGenzymeGenentechOCULAR THERAPEUTIXBausch & LombUCBCares
By Types:Age Related Macular DegenerationDiabetic RetinopathyOcular Inflammatory Disease (Uveitis)Macular Hole
By Applications:HospitalsClinicsOthers
Request To Download Sample of This Strategic Report: -https://reportocean.Us/sample-request/report_id/HNY22026
Key Indicators Analyzed
Market Players & Competitor Analysis:The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2031 & Sales with a thorough analysis of the markets competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2031. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends:Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers:Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
Request Full Report: https://reportocean.Us/sample-request/report_id/HNY22026
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today's competitive environment. Report Ocean is a 'one-stop solution' for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Report Ocean:
Email:sales@reportocean.Com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 - UNITED STATES
Tel:+1888 212 3539 (US - TOLL FREE)
Website:https://reportocean.Us/
COMTEX_430131093/2796/2023-04-25T09:12:56
The MarketWatch News Department was not involved in the creation of this content.
Ocugen's Retinal Therapy Gains FDA Orphan Drug Status
Ocugen has received orphan drug designation from the US Food and Drug Administration for its OCU410ST (AAV5-hRORA) to treat ABCA4–linked retinopathies.
OCU410ST is an adeno-associated virus (AAV) serotype 5 capsid protein, which comprises a gene construct that encodes human retinoic acid receptor (RAR)-related orphan receptor alpha.
It is intended to treat ABCA4-linked retinopathies including retinitis pigmentosa 19 (RP19), Stargardt disease and cone-rod dystrophy 3 (CORD3).
Ocugen chairman, CEO and co-founder Dr Shankar Musunuri stated: "There are approximately 44,000 patients in the US living with ABCA4-associated retinal diseases for whom no treatment options exist.
"This designation acknowledges the potential for OCU410ST to fulfil a significant unmet medical need, and represents an important milestone in our effort to develop innovative treatments for inherited retinal diseases."
Utilising an AAV delivery platform, OCU410ST enables the delivery of the RAR-related orphan receptor A (RORA) gene to the retina.
The ATP-binding cassette (ABC) superfamily transmembrane protein is generated by the ABCA4 gene and is found exclusively in retinal photoreceptors.
The gene mediates the transport and removal of all-trans-retinal aldehyde, a byproduct of the retinoid cycle of vision, from photoreceptor cells.
A mutation in this gene causes Stargardt disease, a rare genetic disorder primarily impacting the retina of the eye. This condition leads to a gradual deterioration of vision in children.
A number of ABCA4 alleles have been found to be responsible for other retinopathies, including CORD3 and RP19.
Ocugen intends to file an investigational new drug application in the second quarter of 2023, with the aim of commencing a Phase I/II clinical study.
Global Retinal Detachment Disorder Market Size To Exceed USD 3.5 Billion By 2030CAGR Of 8.3%
SPHERICAL INSIGHTS LLP
The Global Retinal Detachment Disorder Market Size was valued at USD 1.7 billion in 2021 and the worldwide retinal detachment disorder market size is expected to reach USD 3.5 Billion by 2030, according to a research report published by Spherical Insights & Consulting. Companies Covered: Carl Zeiss Meditec, Centervue SpA, Lab Pensacola, Eyenuk Inc., Imagine Eyes, HealPros, LLC., NEUROVISION IMAGING, LLC., Optos, Peek Vision Ltd. And among others.
New York, United States, April 18, 2023 (GLOBE NEWSWIRE) -- The Global Retinal Detachment Disorder Market Size is To Grow from USD 1.7 Billion in 2021 to USD 3.5 Billion by 2030, at a Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period. The factors which are driving this growing share of the market are emerging markets and significant investment in research and development.
Get a Sample PDF Brochure: https://www.Sphericalinsights.Com/request-sample/1665
A disorder of retinal detachment is a disorder when the retina, the delicate layer of nerve tissue lining the back of the eye, separates from its normal position. Retinal detachment occurs when the layer of blood vessels that feeds and oxygenates the retinal cells becomes detached from them. Retinal detachment is a harmful eye disorder in which a thin layer of tissue (the retina) tears away from its normal place in the back of the eye. Longer instances of untreated retinal detachment raise the possibility of permanent vision loss in the affected eye. There are three main methods by that retinal detachment can happen, such as, rhegmatogenous, tractional, and exudative. According to WHO, about 80% of blindness worldwide is preventable, meaning the disease can be treated if the necessary information and medical measures are given at the appropriate time or arise from certain situations that can be avoided. Retinal breaks, tears, or holes are the most common causes of retinal detachments. Retinal detachment can cause complete or partial blindness, depending on how much of the retina has detached.
The growing technological advancements and an increase in cases of retinal detachment are anticipated to propel the market share. An increase in the number of eye surgeries is also anticipated to drive growth in the market. Moreover, the market is expanding as a result of factors such as an aging population, a rise in the prevalence of eye conditions like diabetic retinopathy, as well as other factors. Increasing numbers of individuals are becoming aware of eye problems such as cataracts, glaucoma, dry eye disease, and others, which enhances the need for eye therapies and is expected to boost market growth during the forecast period. Furthermore, owing to the high cost of the equipment used in retinal surgery, the market growth of retinal detachment conditions is constrained. Additionally, the lack of qualified specialists is a restraint on expansion.
Browse key industry insights spread across 200 pages with 100 market data tables and figures & charts from the report on "Global Retinal Detachment Disorder Market Size, Share, and COVID-19 Impact Analysis, By Type (Rhegmatogenous Retinal Detachment, Tractional Retinal Detachment, Exudative Retinal Detachment), By Treatment (Photocoagulation [Laser Surgery], Cryopexy [Freezing], Pneumatic Retinopexy, Scleral Buckling and Vitrectomy), By End Users (Hospitals, Clinics, Speciality Centers, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa)), Analysis and Forecast 2021 – 2030". Get Detailed Report Description Here:
Buy Now Full Report: https://www.Sphericalinsights.Com/checkout/1665
COVID 19 Impact
The market for retinal detachment disorders has been impacted by COVID-19. The governments-imposed limitations and lockdown measures have interrupted the medical care provided in eye clinics and hospitals, which has reduced the need for equipment. For instance, from the pre-pandemic to the pandemic period, there was a 41.6% decrease in rhegmatogenous retinal detachment (RRD) procedures in France, according to a study that was published in november 2021 in the British Journal of Ophthalmology. As a result, the demand for instruments, accessories, and other surgical items has fallen as a result of the reduced surgical procedures for RD, which has had an influence on market growth throughout the pandemic period. The need for eye surgery has increased, though, as a result of the procedures being resumed and the rise in hospital visits. The market is therefore anticipated to expand and recover.
The rhegmatogenous segment is holding the largest market share over the forecast period.
Based on the types, the global retinal detachment disorder market is bifurcated into different segments include, rhegmatogenous retinal detachment, tractional retinal detachment, and exudative retinal detachment. Among these, the rhegmatogenous segment is dominating the market share over the forecast period due to rhegmatogenous retinal detachment being increasingly prevalent in the older population. According to the United Nations' 2017 "World Aging Population" research, as the world's older population grows, more people are expected to suffer from RRD, and early disorder discovery helps patients avoid financial hardship as a result.
The hospital segment is dominating the market share during the forecast period.
Based on the end users, the global retinal detachment market is segmented into hospitals, clinics, specialty centers, and others. Among these segments, the hospital segment is dominating the largest market share due to the hospital segment offers a variety of treatments for retinal detachment, including surgery, laser therapy, and cryotherapy (freezing), which could boost market share during the projection period. Additionally, hospitals with modern facilities and sufficient resources can treat the growing number of individuals who suffer from this disorder.
Inquire Before Buying This Research Report: https://www.Sphericalinsights.Com/inquiry-before-buying/1665
Global Retinal Detachment Disorder Market, By Treatment
The retinal detachment market, by treatment, has been segmented into different segments, such as photocoagulation (laser surgery), cryopexy (freezing), pneumatic retinopexy, scleral buckling, and vitrectomy.
North America is dominating the largest market share of 41.3% during the forecast period
North America accounts for the largest market share during the forecast period, owing to the Increasing awareness of retinal detachment in this region and an increase in the number of patients with this condition. Furthermore, due to the presence of a strong healthcare infrastructure with access to cutting-edge technologies, this region would dominate the market during the projected period
The Asia Pacific region is predicted to expand at the fastest growth rate over the projected period, due to a growing elderly population and efficient reimbursement policies.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the Global Retinal Detachment Disorder Market include Carl Zeiss Meditec AG, Meridian AG, IRIDEX Corporation, Ellex Medical Lasers Ltd, FCI, Millennium Surgical Corp., BVM Medical Limited, Lombart Instrument, Inc., Welch Allyn, and many others.
Get Discount At @ https://www.Sphericalinsights.Com/request-discount/1665
Recent Development
December 2022: In Vashi, Navi Mumbai, ASG Eye Hospitals opened a brand-new specialist eye hospital for the treatment of simple to the most complex eye disorder. The hospital provides scleral buckling operations, vitrectomy treatments, and pneumatic retinopexy procedures for retinal detachment.
Browse Related Reports
Global Phenylketonuria Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Drugs, Nutrition Supplements, Others), By Type (Hyperphenylalaninemia, Mild PKU, Moderate and Variant, Classic PKU), By End Users (Hospital Pharmacies, Online Pharmacies, Drug Stores, Pediatric Clinics, & Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022– 2032
https://www.Sphericalinsights.Com/reports/phenylketonuria-market
Global Axial Spondyloarthritis (axSpA) Market Size, Share, and COVID-19 Impact Analysis, By Types (Ankylosing spondylitis (AS) and Non-radiographic axial spondyloarthritis (nr-axSpA), By Drug Class (Non-steroidal anti-inflammatory drugs (NSAID), Glucocorticoids, Anti-rheumatic drugs, & Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032
https://www.Sphericalinsights.Com/reports/axial-spondyloarthritis-axspa-market
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.Com, sales@sphericalinsights.Com
Contact Us: https://www.Sphericalinsights.Com/contact-us
Follow Us: LinkedInFacebookTwitter
Comments
Post a Comment